Evidence-Based Dermatology: Research Commentary
December 2002

Systematic Review of Imiquimod for the Treatment of Genital Warts: All That Glitters Is Not Gold

Author Affiliations

MichaelBigbyMDRosamariaCoronaDSc, MDDamianoAbeniMD, MPHPaoloPaolo PasquiniMD, MPHMoysesSzkloMD, MPH, DrPHHywelWilliamsMD


Copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2002

Arch Dermatol. 2002;138(12):1599-1601. doi:10.1001/archderm.138.12.1599

Question: In immunocompetent patients with external genital warts, what are the benefits and the harms of imiquimod therapy?

Data Sources: Studies were identified through a search of MEDLINE (1966-2000), the Cochrane Library (issue 3, 2000), and PubMed (December 15, 2000). Reference lists of review articles were searched for additional trials, and the manufacturers of 5% imiquimod cream were asked about clinical trials. Authors of articles were not contacted for unpublished reports or for additional information from published reports. No restrictions to language were made.

First Page Preview View Large
First page PDF preview
First page PDF preview